Technology ❯ Biotechnology ❯ Gene Editing

CRISPR-Cas9

Molecular Tools Therapeutics Applications in Research

Intellia Pauses Phase 3 Trials of CRISPR Therapy After Severe Liver Event

A protocol-triggering Grade 4 liver event in a recently dosed participant prompted regulatory engagement alongside expert review.

CRISPR Epigenome Editing Controls Inflammation and Tumor Growth in Leukemia Cells